In Depth 23 May 2024
Is prime editing ready for prime time?
Prime editing, a more advanced version of CRISPR/Cas9 technology, has been greenlit by the FDA to begin the first-ever clinical trial for this technology.
In Depth
- Latest Posts
In Depth 22 May 2024
The undruggable cancer target: KRAS inhibitors move ahead in the clinic
Uncover the promise of KRAS inhibitors in cancer treatment, as evidenced by a $200 million investment in BridgeBio’s spinout.
In Depth 15 May 2024
Drugs for IgA nephropathy on the rise in the clinic
As we observed IgA Nephropathy Awareness Day on May 14th, let us take a look at ongoing clinical trials for drugs that aim to make patient lives better.
In Depth 13 May 2024
New antidepressants: tackling treatment resistant depression
Take a look at how new antidepressants can more effectively tackle treatment resistant depression compared to more traditional treatments.
In Depth 9 May 2024
BTK inhibitors: can these drugs tackle cancer and autoimmunity?
BTK inhibitors were first approved over a decade ago to treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune diseases.
In Depth 9 May 2024
The biggest private biotech investments in April 2024
The companies Xaira Therapeutics, Metsera, and Obsidian Therapeutics bagged the biggest private biotech investments in April 2024.
ADVERTISEMENT
ADVERTISEMENT
In Depth 8 May 2024
New treatment for pulmonary hypertension: what biotech holds in store?
While it has been about managing pulmonary hypertension’s symptoms for a long time, new treatments are adressing the root of the disease.
In Depth 6 May 2024
The rise of Spain: A key player in global clinical trials
Spain has climbed the research and development ladder in recent years, and has made it to the top as one of the world leaders in the life science industry.
In Depth 3 May 2024
Can emerging new treatments lead the way to cure Duchenne muscular dystrophy?
Delve into the new treatment approaches to Duchenne muscular dystrophy, a challenging disease for those suffering from it, and research.
In Depth 2 May 2024
New treatments for cystic fibrosis: boosting life expectancy
Discover how cystic fibrosis treatments are extending life expectancy, with recent advancements set to increase it by 75% by next year.
In Depth 29 Apr 2024
Can Brazil make cell and gene therapy costs affordable for all?
Found out how Brazil is attempting to make gene and cell therapy costs affordable for all with a new initiative.
In Depth 26 Apr 2024
How to overcome clinical trial challenges
How can companies overcome clinical trial challenges? Sheila Rocchio from eClinical Solutions and Gen Li from Phesi explain.
ADVERTISEMENT